George O. Elston
George O. Elston founded Chatham Street Partners. Currently, Mr. Elston is CFO & Head-Corporate Development at EyePoint Pharmaceuticals, Inc. He is also on the board of db-X ETF Trust.
Mr. Elston previously held the position of Chief Operating & Financial Officer of Optherion, Inc., Managing Partner at Chatham Street Partners, President & Chief Executive Officer at Oncology Venture US, Inc., President & Chief Executive Officer for Enzyvant, Inc., Chief Financial Officer, Secretary & Treasurer of Catalent JNP, Inc., Vice President-Finance & Government Affairs at Elusys Therapeutics, Inc., Chief Financial Officer & Senior Vice President of KBI Biopharma, Inc., Chief Financial Officer of Trillium USA, Inc., Principal at C. R. Bard, Inc. (New Jersey) and Principal at Pricewaterhousecoopers LLC.
He received an undergraduate degree from Pace University.
Transactions
| 09/04/2020 | 10,000 | Acquisition at $0.48 per share. | 4,800 |
| 08/24/2020 | 10,000 | Acquisition at $0.61 per share. | 6,100 |
| 03/12/2020 | 10,000 | Acquisition at $0.96 per share. | 9,600 |
| 11/15/2019 | 10,000 | Acquisition at $1.43 per share. | 14,300 |
